Wholesale of pharmaceutical and medical goods
IMPLANTSCAN AS
Revenue 2024
NOK 20.6m
Operating profit
NOK −782,000
Equity
NOK 1.3m
Incorporated
2006
Employees
5
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 20.6m | |
| Total operating costs | 21.4m | |
| Operating profit (EBIT) | −782k | |
| Net financial items | −155k | |
| Profit for the year | −937k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 10.6m | |
| of which current assets | 8.7m | |
| Equity | 1.3m | |
| Total liabilities | 9.3m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.